Insulin and Antidiabetic Agents-The Old and the New

Journal of Perianesthesia Nursing

Volumn 21, Issue 2, 2006, Pages 131-134

  Golembiewski, Julie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; CLASSIFICATION; DRUG APPROVAL; DRUG COMBINATION; FOOD AND DRUG ADMINISTRATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG APPROVAL; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33645965898     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jopan.2006.01.001     Document Type: Article

References (12)

1. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes; new perspectives on disease pathogenesis and treatment. Lancet 358 (2000) 221-229
2. Gerich J.E. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes. Mayo Clin Proc 78 (2003) 447-456
3. Defronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM, a balanced overview. Diabetes Care 15 (1992) 318-366
4. UK prospective Diabetes Study Group. UK Prospective Diabetes Study 16: Overview of 6 years' therapy of type 2 diabetes: A progressive disease. Diabetes 44 (1995) 1249-1258
5. Cook D.L., and Taborsky Jr. G.J. B-cell function and insulin secretion. In: Porte D., and Sherwin R.S. (Eds). Ellenberg and Rifkin's Diabetes Mellitus. 5th ed. (1997), Lippincott-Raven, Philadelphia, PA 49-73
6. Oiknine R., Bernbaum M., and Mooradian A.D. A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Drugs 65 (2005) 325-340
7. Mehanna A.S. Insulin and oral antidiabetic agents. Am J Pharm Educat 69 (2005) (5):Article 89.
8. Donnelly A.J., Baughman V.L., Gonzales J.P., et al. Anesthesiology and Critical Care Handbook. 6th ed. (2005), Lexi-Comp, Hudson, OH
9. Osterweil N. FDA advisors endorse inhaled insulin Exubera. CME teaching brief, MedPage today (2005). http://money.cnn.com/2005/09/08/news/fortune500/exubera Available at: http://money.cnn.com/2005/09/08/news/fortune500/exubera. Accessed December 28
10. FDA news. FDA approves first ever inhaled insulin combination product for treatment of diabetes. Available at: http://www.fda.gov/bbs/topics/news/2006/NEW01304.html. Accessed December 28, 2005.
11. Inzucchi S.E. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 287 (2002) 360-372
12. Hussar D.A. New drugs. Exenatide, pramlintide acetate, and micafungin sodium. J Am Pharm Assoc 45 (2005) 524-526